NVP-BEZ235 overcomes gefitinib-acquired resistance by down-regulating PI3K/AKT/ mTOR phosphorylation

Gang Wu(Hubei University of Chinese Medicine), Sheng Zhang(Tongji University)
OncoTargets and Therapy
January 1, 2015
Cited by 26


Related Papers